KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Prepaid Assets (2019 - 2025)

Historic Prepaid Assets for Royalty Pharma (RPRX) over the last 7 years, with Q3 2025 value amounting to $5.5 million.

  • Royalty Pharma's Prepaid Assets rose 1106.86% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 1106.86%. This contributed to the annual value of $4.2 million for FY2024, which is 7679.05% down from last year.
  • Per Royalty Pharma's latest filing, its Prepaid Assets stood at $5.5 million for Q3 2025, which was up 1106.86% from $4.5 million recorded in Q2 2025.
  • Over the past 5 years, Royalty Pharma's Prepaid Assets peaked at $90.5 million during Q4 2022, and registered a low of $2.3 million during Q2 2024.
  • Its 5-year average for Prepaid Assets is $18.8 million, with a median of $6.6 million in 2021.
  • In the last 5 years, Royalty Pharma's Prepaid Assets soared by 126510.33% in 2022 and then plummeted by 9250.51% in 2023.
  • Quarter analysis of 5 years shows Royalty Pharma's Prepaid Assets stood at $6.6 million in 2021, then soared by 1265.1% to $90.5 million in 2022, then crashed by 80.07% to $18.0 million in 2023, then tumbled by 76.79% to $4.2 million in 2024, then skyrocketed by 31.81% to $5.5 million in 2025.
  • Its last three reported values are $5.5 million in Q3 2025, $4.5 million for Q2 2025, and $3.1 million during Q1 2025.